| scholarly article | Q13442814 |
| P50 | author | Tsz Kin Ng | Q38548202 |
| P2093 | author name string | Herman S Cheung | |
| Daniel Pelaez | |||
| Veronica R Fortino | |||
| P2860 | cites work | Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future? | Q21285056 |
| Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) | Q24236316 | ||
| Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction | Q24534652 | ||
| Autism | Q24629445 | ||
| Stem cell therapy for autism | Q24676771 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Global incidence and prevalence of traumatic spinal cord injury | Q38115844 | ||
| Children with autism spectrum disorder at a pediatric hospital: a systematic review of the literature | Q38127427 | ||
| Immunomodulatory effects of stem cells | Q38127784 | ||
| HTRA1 in Age-Related Macular Degeneration | Q38536706 | ||
| Adipose derived mesenchymal stem cells partially rescue mitomycin C treated ARPE19 cells from death in co-culture condition | Q39146040 | ||
| Prospects of Stem Cells for Retinal Diseases | Q39495347 | ||
| Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats | Q39584385 | ||
| Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord | Q39785047 | ||
| HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury | Q43201422 | ||
| Isolation of multipotent stem cells in human periodontal ligament using stage-specific embryonic antigen-4. | Q43234232 | ||
| Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats | Q43619965 | ||
| High yield of cells committed to the photoreceptor-like cells from conjunctiva mesenchymal stem cells on nanofibrous scaffolds. | Q44540689 | ||
| Subretinal transplantation of rat MSCs and erythropoietin gene modified rat MSCs for protecting and rescuing degenerative retina in rats | Q45856141 | ||
| Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model | Q46075579 | ||
| Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells | Q46110174 | ||
| Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion | Q46196929 | ||
| Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells | Q46350398 | ||
| Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. | Q47605121 | ||
| Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. | Q48399250 | ||
| Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. | Q50719908 | ||
| Effects of bone marrow stromal cell injection in an experimental glaucoma model. | Q50732297 | ||
| A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury | Q56775114 | ||
| Mesenchymal stem cells from trabecular meshwork become photoreceptor-like cells on amniotic membrane | Q57776937 | ||
| Autism spectrum disorders | Q63536775 | ||
| Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand | Q73035541 | ||
| Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex | Q78833880 | ||
| Primary open-angle glaucoma | Q80122027 | ||
| Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans | Q83388889 | ||
| Interactive expressions of HtrA1 and VEGF in human vitreous humors and fetal RPE cells | Q83395475 | ||
| Mesenchymal stem cells | Q83591416 | ||
| Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines | Q28216281 | ||
| Multiple sclerosis | Q29616022 | ||
| Retinitis pigmentosa | Q29616538 | ||
| Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 | ||
| Mesenchymal stem cells | Q29619804 | ||
| The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications | Q30664381 | ||
| 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies | Q30944227 | ||
| Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma | Q33516457 | ||
| Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology | Q33532634 | ||
| A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype | Q33570359 | ||
| Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options | Q34109632 | ||
| Differentiation of mesenchymal stem cell in the microenviroment of retinitis pigmentosa | Q34254500 | ||
| Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis | Q34564111 | ||
| The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments | Q34686955 | ||
| Recent advances in pathophysiology and treatment of spinal cord injury | Q35005402 | ||
| A clinician's view of spinal cord injury | Q35078692 | ||
| Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells | Q35166506 | ||
| Plasticity of adult stem cells | Q35684656 | ||
| Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study | Q35757641 | ||
| The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis | Q36054671 | ||
| Safety issues with drug therapies for autism spectrum disorders. | Q36364010 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism | Q37153167 | ||
| Concise review: mesenchymal stromal cells: potential for cardiovascular repair. | Q37206855 | ||
| Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. | Q37253314 | ||
| Number of people with glaucoma worldwide | Q37320324 | ||
| The medical and surgical treatment of glaucoma | Q37405146 | ||
| Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo | Q37517380 | ||
| Phenotypes of stem cells from diverse origin | Q37660233 | ||
| Animal models of multiple sclerosis--potentials and limitations | Q37766015 | ||
| Neurotrophic factor delivery as a protective treatment for glaucoma | Q37777778 | ||
| Experimental reconstruction of the injured spinal cord | Q37945528 | ||
| The molecular basis of retinal ganglion cell death in glaucoma | Q37966513 | ||
| Current immunotherapy of multiple sclerosis and future challenges: relevance of immune-mediated repair | Q37984515 | ||
| Autism research and services for young children: history, progress and challenges | Q38081111 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 111-119 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | World Journal of Stem Cells | Q27723407 |
| P1476 | title | Progress of mesenchymal stem cell therapy for neural and retinal diseases | |
| P478 | volume | 6 |
| Q54956395 | Assessment of Central Visual Function in Patients with Retinitis Pigmentosa. |
| Q89461661 | Bone marrow mesenchymal stem cells enhance autophagy and help protect cells under hypoxic and retinal detachment conditions |
| Q55402017 | Branched chain amino acids attenuate major pathologies in mouse models of retinal degeneration and glaucoma. |
| Q61479610 | Changes in morphology and visual function over time in mouse models of retinal degeneration: an SD-OCT, histology, and electroretinography study |
| Q33846469 | Compound anisodine affects the proliferation and calcium overload of hypoxia-induced rat retinal progenitor cells and brain neural stem cells via the p-ERK1/2/HIF-1α/VEGF pathway |
| Q38443625 | Current focus of stem cell application in retinal repair |
| Q26865832 | Current perspectives in mesenchymal stem cell therapies for osteoarthritis |
| Q64277481 | Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex I defect-induced degeneration |
| Q36424207 | Effects of Serial Passage on the Characteristics and Cardiac and Neural Differentiation of Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells |
| Q35279648 | Encapsulating non-human primate multipotent stromal cells in alginate via high voltage for cell-based therapies and cryopreservation |
| Q92996953 | Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System |
| Q36577074 | Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine? |
| Q37638099 | Experimental Study of the Biological Properties of Human Embryonic Stem Cell-Derived Retinal Progenitor Cells |
| Q38709705 | Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System |
| Q36996649 | Gender difference in the neuroprotective effect of rat bone marrow mesenchymal cells against hypoxia-induced apoptosis of retinal ganglion cells. |
| Q87401824 | Genetic variants of interleukin 17A are functionally associated with increased risk of age-related macular degeneration |
| Q35871811 | Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia- Specific Proteins |
| Q40171550 | Human Embryonic Stem Cells in the Treatment of Autism: A Case Series |
| Q36939755 | Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. |
| Q29994669 | Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy |
| Q48827577 | Immunophenotypic characterization of ovine mesenchymal stem cells. |
| Q91737517 | Improved therapeutic potential of MSCs by genetic modification |
| Q38646267 | Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis |
| Q38679475 | Management of glaucoma as a neurodegenerative disease |
| Q37677012 | Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage |
| Q28072497 | Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials |
| Q32186021 | Mesenchymal stem cells attenuate hydrogen peroxide-induced oxidative stress and enhance neuroprotective effects in retinal ganglion cells |
| Q38317505 | Metabolic restructuring and cell fate conversion |
| Q37243413 | Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke |
| Q41976417 | Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration |
| Q91792402 | Ocular progenitor cells and current applications in regenerative medicines - Review |
| Q92310320 | Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture |
| Q37542184 | Peripheral Inflammatory Markers Contributing to Comorbidities in Autism. |
| Q36386720 | Polydatin Protects Bone Marrow Stem Cells against Oxidative Injury: Involvement of Nrf 2/ARE Pathways |
| Q38526185 | Present and New Treatment Strategies in the Management of Glaucoma |
| Q50042214 | Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review |
| Q41850476 | Remyelination improvement after neurotrophic factors secreting cells transplantation in rat spinal cord injury. |
| Q34232871 | Renal stem cell reprogramming: Prospects in regenerative medicine |
| Q36416719 | Reprogramming somatic cells to cells with neuronal characteristics by defined medium both in vitro and in vivo. |
| Q48913622 | Scalable Expansion of Human Pluripotent Stem Cell-Derived Neural Progenitors in Stirred Suspension Bioreactor Under Xeno-free Condition |
| Q35959608 | Spinal cord injury in rats treated using bone marrow mesenchymal stem-cell transplantation |
| Q35838003 | Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report |
| Q38818152 | Stem Cell Sources and Their Potential for the Treatment of Retinal Degenerations. |
| Q26795447 | Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century |
| Q58805404 | Stem cell therapy for retinal ganglion cell degeneration |
| Q55640649 | Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury model. |
| Q89928436 | Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review |
| Q91722941 | miRNA-based therapeutic potential of stem cell-derived extracellular vesicles: a safe cell-free treatment to ameliorate radiation-induced brain injury |
Search more.